Sales 2024 * | 2.67B 3.64B | Sales 2025 * | 2.79B 3.81B | Capitalization | 2.06B 2.81B |
---|---|---|---|---|---|
Net income 2024 * | -84M -115M | Net income 2025 * | 23M 31.43M | EV / Sales 2024 * | 1.65 x |
Net Debt 2024 * | 2.35B 3.21B | Net Debt 2025 * | 2.12B 2.9B | EV / Sales 2025 * | 1.5 x |
P/E ratio 2024 * |
-24.7
x | P/E ratio 2025 * |
95.1
x | Employees | - |
Yield 2024 * |
0.45% | Yield 2025 * |
-
| Free-Float | 26.95% |
Latest transcript on Impax Laboratories Inc
Managers | Title | Age | Since |
---|---|---|---|
Chirag K. Patel
FOU | Founder | 57 | 01-12-31 |
Chintu Patel
FOU | Founder | 53 | 01-12-31 |
Director of Finance/CFO | 57 | 11-06 |
Members of the board | Title | Age | Since |
---|---|---|---|
Ted Nark
BRD | Director/Board Member | 66 | 11-06 |
J. Buchi
BRD | Director/Board Member | 69 | 11-06 |
Paul Meister
CHM | Chairman | 71 | 11-06 |
1st Jan change | Capi. | |
---|---|---|
+29.40% | 684B | |
+29.15% | 568B | |
-4.02% | 361B | |
+18.74% | 329B | |
+4.68% | 284B | |
+15.94% | 240B | |
+9.32% | 208B | |
-7.03% | 200B | |
+7.69% | 166B |